Eras of Designer Tregs: Harnessing Synthetic Biology for Immune Suppression

The year 2022 marked the entry of “designer” Tregs into the clinic, with exciting potential for application and efficacy in a wide variety of immune-mediated diseases. The authors review the development of designer Tregs through the perspective of three ‘eras’ leading up to this.